Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendations
2
Issued Date
2024-01-01
Resource Type
ISSN
14732130
eISSN
14732165
Scopus ID
2-s2.0-85184233625
Journal Title
Journal of Cosmetic Dermatology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Cosmetic Dermatology (2024)
Suggested Citation
Metelitsa A., Enright K.M., Rosengaus F., Avelar L., Lam S., Berros P., Di Gregorio C., Fabi S., Hamdan F., Liew S., Minocha K., Wanitphakdeedecha R., Weiner S., Nikolis A. Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendations. Journal of Cosmetic Dermatology (2024). doi:10.1111/jocd.16207 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/97179
Title
Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendations
Author's Affiliation
Siriraj Hospital
Institut de Recherche en Immunologie et en Cancérologie de l’Université de Montréal
University of California, San Diego
University of Calgary
Highness Clinics
L'ART by Dr M
Central Health Medical Practice
Dr. Rosengaus Clinic
The Aesthetic Clinique
Clinica Domani Luiz Avelar
Beacon Dermatology
Highness Beauty Clinics
Centre Medical International Monaco
Shape Clinic
Private Practice
Institut de Recherche en Immunologie et en Cancérologie de l’Université de Montréal
University of California, San Diego
University of Calgary
Highness Clinics
L'ART by Dr M
Central Health Medical Practice
Dr. Rosengaus Clinic
The Aesthetic Clinique
Clinica Domani Luiz Avelar
Beacon Dermatology
Highness Beauty Clinics
Centre Medical International Monaco
Shape Clinic
Private Practice
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: The Restylane portfolio of soft tissue fillers spans a wide range of indications, due in part to their complementary manufacturing technologies [non-animal stabilized hyaluronic acid (NASHA) and Optimal Balance Technology (OBT/XpresHAn)]. Using an array of products, injectors can achieve a holistic, natural looking effect for their patients. However, with a wide range of products it may be difficult to choose an optimal combination. Aim: Simplify and align global use recommendations for NASHA versus OBT products. Methods: Two pre-meeting surveys were completed by 11 key opinion leaders with international representation, with the goal of collecting information regarding their current injection practices for various anatomical regions of the face (i.e., temporal region, forehead, tear trough, lateral zygoma, anteromedial cheek, nose, pyriform aperture, nasolabial fold, perioral area, lips, labiomental crease, marionette lines, chin, and jawline). The data collected from these surveys was subsequently discussed in a consensus group meeting involving 11 voting members and 3 nonvoting members. Results: Top product recommendations were identified for each anatomical area, along with secondary and tertiary recommendations that can also be used under defined circumstances. Recommendations were provided based on a consideration of elements such as patient features (e.g., skin thickness, bone structure), the desired aesthetic outcome, experience of the injector, and the preferred injection technique. Conclusion: A majority consensus regarding the top NASHA versus OBT product choice for each anatomical region of the face was reached. These recommendations represent international agreement regarding the use of Restylane products.